These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 11467888)

  • 1. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.
    Sadowski T; Steinmeyer J
    Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes.
    Sadowski T; Steinmeyer J
    Biochem Pharmacol; 2002 Jul; 64(2):217-27. PubMed ID: 12123742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1.
    Sadowski T; Steinmeyer J
    Inflamm Res; 2001 Mar; 50(3):175-82. PubMed ID: 11339506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
    Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
    Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes.
    Sadowski T; Steinmeyer J
    Inflamm Res; 2002 Aug; 51(8):427-33. PubMed ID: 12234061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
    Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
    Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-inflammatory IL-1beta and/or TNF-alpha up-regulate matrix metalloproteases-1 and -3 mRNA in chondrocyte subpopulations potentially pathogenic in osteoarthritis: in situ hybridization studies on a single cell level.
    Kunisch E; Kinne RW; Alsalameh RJ; Alsalameh S
    Int J Rheum Dis; 2016 Jun; 19(6):557-66. PubMed ID: 25291965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
    Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
    J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes.
    Tanigawa S; Aida Y; Kawato T; Honda K; Nakayama G; Motohashi M; Suzuki N; Ochiai K; Matsumura H; Maeno M
    Cytokine; 2011 Nov; 56(2):376-86. PubMed ID: 21885294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
    Dunn SL; Wilkinson JM; Crawford A; Le Maitre CL; Bunning RA
    Osteoarthritis Cartilage; 2014 Jan; 22(1):133-44. PubMed ID: 24211233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
    Hui A; Min WX; Tang J; Cruz TF
    Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes.
    Kim HA; Yeo Y; Kim WU; Kim S
    Rheumatology (Oxford); 2009 Aug; 48(8):932-8. PubMed ID: 19491303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.
    Lee YJ; Lee EB; Kwon YE; Lee JJ; Cho WS; Kim HA; Song YW
    Rheumatol Int; 2003 Nov; 23(6):282-8. PubMed ID: 12684836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
    J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes.
    Yamada H; Kikuchi T; Nemoto O; Obata K; Sato H; Seiki M; Shinmei M
    J Rheumatol; 1996 Oct; 23(10):1739-43. PubMed ID: 8895151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures.
    Tung JT; Arnold CE; Alexander LH; Yuzbasiyan-Gurkan V; Venta PJ; Richardson DW; Caron JP
    Am J Vet Res; 2002 Jul; 63(7):987-93. PubMed ID: 12118680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
    Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
    Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes.
    Su S; Dehnade F; Zafarullah M
    DNA Cell Biol; 1996 Dec; 15(12):1039-48. PubMed ID: 8985117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.